Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2021 08:15 ET | Source: Scynexis

SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China

Hansoh Pharma, one of the largest biopharmaceutical companies in Greater China and in Asia, provides fully integrated R&D, manufacturing, and commercial capabilities to accelerate entry of...
February 17, 2021 08:00 ET | Source: Imcyse S.A.

Imcyse Raises Additional EUR 21.3 Million in Series B Financing Round - Pfizer Joins as Newest Shareholder

Pfizer takes equity stake in Imcyse as part of the recently announced Rheumatoid Arthritis license agreementMajor existing shareholders participated in the roundProceeds to advance Imcyse’s pipeline...
February 17, 2021 08:00 ET | Source: Emergen Research

Specialty Enzymes Market size to Reach USD 8.21 Billion by 2028 | Cost-Effective and Eco-Friendly Aspects of Specialty Enzymes is Driving Industry Growth, says Emergen Research

Vancouver, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The global specialty enzymes market size was USD 4.45 Billion in 2020 and is projected to reach a market size of USD 8.21 Billion at a...
February 17, 2021 08:00 ET | Source: Selecta Biosciences, Inc.

Selecta Biosciences and AskBio Initiate First-in-Human Dose-Escalation Study to Evaluate ImmTOR™ in Gene Therapy

– Clinical trial commences in healthy adult volunteers to determine appropriate dose of ImmTOR to mitigate formation of antibodies to AAV capsids used in gene therapy – WATERTOWN, Mass. and RESEARCH...
February 17, 2021 08:00 ET | Source: CORHIO

Health Current Selects NowPow as Technology Partner to Implement a Statewide Social Determinants of Health Closed Loop Referral System in Arizona

Phoenix, Ariz., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Health Current, Arizona’s health information exchange (HIE), today announced the selection of NowPow as the vendor of choice for Arizona’s closed...
February 17, 2021 07:57 ET | Source: Adroit Market Research

Cell Therapy Market to reach USD 7.85 billion by 2028 - Global Insights on Trends, COVID-19 Impact Analysis, Growth Opportunities, Strategic initiatives and Future Outlook: Adroit Market Research

Dallas, Texas, Feb. 17, 2021 (GLOBE NEWSWIRE) -- The “Global Cell Therapy Market Size 2020, By Use-Type (Clinical-Use And Research-Use) Therapy Type (Autologous And Allogeneic) Region (North...
February 17, 2021 07:48 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Provides Update on COVID-19 Phase 2b Final Study Data

VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
February 17, 2021 07:45 ET | Source: AREV NanoTec Brands Inc.

AREV’s Nanotech initiates early-stage antiviral photochemistry derivation discovery program for pandemic viral pathogens

VANCOUVER, British Columbia, Feb. 17, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec”), is pleased to announce that AREV is utilizing its proprietary...
February 17, 2021 07:30 ET | Source: Otonomy, Inc.

Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting

Presentation of positive top-line clinical results for OTO-313 in tinnitus and OTO-413 in hearing lossSupportive preclinical data to be presented for OTO-825 gene therapy and OTO-510 otoprotection...
February 17, 2021 07:30 ET | Source: Harpoon Therapeutics

Harpoon Therapeutics to Participate in SVB Leerink Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today...